Arvinas is a biotechnology company focused on targeted protein degradation that employs roughly 380 people. Recent staffing data show 17 new additions and 29 departures, yielding a slight net decrease in overall headcount. The organization’s size and hiring patterns reflect the resource needs typical of a clinical-stage life-sciences firm that balances research, development, and corporate functions.
Engineering is Arvinas’ largest team with 158 employees, accounting for a little more than 40 % of total staff and underscoring the company’s research-driven focus. Business Management follows with 49 employees, while Healthcare functions, which include clinical and medical roles, comprise 38 people. Operations, Finance & Administration, and Marketing & Product collectively represent about 80 employees, providing the infrastructure required to advance drug candidates and support commercialization plans. Smaller groups such as Consulting and Education contribute niche expertise, and 53 employees are categorized in Other roles that cut across multiple disciplines.
Arvinas maintains a strong presence in Connecticut, with 84 employees in its New Haven headquarters and smaller clusters in Greater Hartford, Guilford, Branford, and Wallingford. The company also staffs 51 people in New York City and has additional concentrations in Boston, Chicago, and Greater Philadelphia. More than half of employees—about 190—work in remote or unspecified locations, suggesting a flexible or distributed workforce model that supports both laboratory operations and field-based activities.